Purchase Order 75N92E24P00031

Award Date 3/3/24
Potential Completion Date 3/2/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order contract, valued at $5,088, was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract provides for the purchase of Illumina sequencing systems, reagents, and related products to support genomic research and analysis. Illumina has been a long-standing supplier of sequencing goods and services to various federal agencies, including the NIH, CDC, USDA, and VA. The...
This is a firm fixed price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $399,983.62. The contract was not set aside for any specific business size or type. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, will provide a range of sequencing systems, reagents, and services to support NHGRI's genomic research and analysis...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $56,416 award does not have a set-aside designation. The order is for Illumina's sequencing systems and related consumables to support genomic research and analysis activities at NHGRI. Illumina has previously received other prime...
This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $20,663.57 firm fixed price delivery order provides Illumina sequencing systems, reagents, and related goods and services to support genomic sequencing and analysis for research and diagnostic purposes across various federal agencies. Illumina has a history of prior prime contract awards with the NIH, CDC, USDA, VA, and...
This firm fixed-price delivery order was awarded to Illumina, Inc. by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The $9,909.50 contract is not set-aside and provides for the delivery of Illumina's proprietary sequencing systems, reagents, and associated services to support genomic sequencing and analysis research at NHGRI. Illumina has a history of providing similar goods and services to other federal...
This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The $149,950.32 contract is for the provision of Illumina's genomic sequencing systems, reagents, and related services to support research and diagnostic applications. Illumina has a history of providing sequencing products and services to federal agencies including the NIH, CDC, USDA, and VA. The award is not...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $498,777.14 contract is to provide Illumina sequencing systems, reagents, and services to support genomic sequencing and analysis for NHGRI's research and diagnostic needs. Illumina has been awarded multiple federal contracts and sub-grants by agencies such as the National...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for $17,149.00. The award is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide sequencing platforms, consumables, and services...
This firm fixed-price purchase order contract was awarded by the National Human Genome Research Institute, a component of the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $16,691.74 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously been awarded prime federal...

This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any set-aside provisions. Illumina has previously received prime federal contract and sub-grant awards from various government agencies, including the Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs, to provide similar sequencing platforms and related products and services. The company also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, worth up to $3.3 million, for the supply of reagents and controls for Illumina's sequencing instruments.

Generated 4/2/25, 10:11 AM